InMode Ltd.
$14.57
▲
0.66%
2026-04-21 07:32:00
www.inmodemd.com
NMS: INMD
Explore InMode Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$923.14 M
Current Price
$14.57
52W High / Low
$16.74 / $12.72
Stock P/E
9.84
Book Value
$10.78
Dividend Yield
—
ROCE
12.27%
ROE
13.53%
Face Value
—
EPS
$1.43
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
660
Beta
2.12
Debt / Equity
1.2
Current Ratio
9.88
Quick Ratio
8.83
Forward P/E
8.84
Price / Sales
2.31
Enterprise Value
$310.14 M
EV / EBITDA
3.6
EV / Revenue
0.84
Rating
None
Target Price
$17
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
- Valuation is not stretched on P/E basis.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | electroCore, Inc. | $6.31 | — | $51.01 M | — | -179.71% | -4.79% | $8.64 / $4.16 | $-0.21 |
| 2. | Integer Holdings Corporation | $89.32 | 29.89 | $3.07 B | — | 7.52% | 6.11% | $127.56 / $62 | $50.85 |
| 3. | Edwards Lifesciences Corporation | $81.27 | 44.98 | $46.93 B | — | 13.77% | 10.35% | $87.89 / $68.63 | $17.8 |
| 4. | Cytosorbents Corporation | $0.65 | — | $41.24 M | — | -41.3% | -96.39% | $1.39 / $0.5 | $0.09 |
| 5. | Artivion, Inc. | $38.8 | 193.48 | $1.89 B | — | 3.41% | 2.7% | $48.25 / $22.22 | $9.37 |
| 6. | Baird Medical Investment Holdings Limited | $1.79 | 55.75 | $64.64 M | — | 35.34% | -8.03% | $7.26 / $0.76 | $1.34 |
| 7. | Nano-X Imaging Ltd. | $2.15 | — | $181.72 M | — | -28.95% | -34.75% | $5.86 / $2.11 | $2.4 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 103.85 M | 93.17 M | 95.6 M | 77.87 M | 97.85 M | — |
| Operating Profit | 25.99 M | 20.9 M | 22.88 M | 15.62 M | 27.86 M | — |
| Net Profit | 27.02 M | 21.86 M | 26.74 M | 18.2 M | 82.77 M | — |
| EPS in Rs | 0.43 | 0.35 | 0.42 | 0.29 | 1.31 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 370.5 M | 394.82 M | 492.05 M | 454.27 M |
| Operating Profit | 85.39 M | 112.53 M | 195.66 M | 197.85 M |
| Net Profit | 93.83 M | 181.28 M | 197.92 M | 161.52 M |
| EPS in Rs | 1.48 | 2.86 | 3.12 | 2.55 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 766.43 M | 785.67 M | 863.29 M | 644.41 M |
| Total Liabilities | 83.23 M | 81.85 M | 75.91 M | 89.79 M |
| Equity | 683.2 M | 703.81 M | 787.37 M | 554.62 M |
| Current Assets | 698.62 M | 714.45 M | 845.33 M | 629.37 M |
| Current Liabilities | 70.74 M | 69.85 M | 64.14 M | 82.02 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 85.26 M | 132.66 M | 176.83 M | 181.58 M |
| Investing CF | 186.03 M | 162.21 M | -136.06 M | -109.47 M |
| Financing CF | -126.06 M | -282.77 M | 5.5 M | -41.09 M |
| Free CF | 84.28 M | 132 M | 176.12 M | 180 M |
| Capex | -0.97 M | -0.67 M | -0.7 M | -1.57 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -19.76% | 8.32% | — | — |
| Earnings Growth % | -8.41% | 22.54% | — | — |
| Profit Margin % | 45.91% | 40.22% | 35.56% | — |
| Operating Margin % | 28.5% | 39.76% | 43.55% | — |
| Gross Margin % | 80.31% | 83.6% | 83.82% | — |
| EBITDA Margin % | 28.69% | 39.89% | 43.7% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2021-10-01 | 1:2 |